Form 4: Apollomics CFO Executes RSU Vesting Transaction

CFO Peter Kuan-How Lin acquired 10,000 Class A Ordinary Shares via RSU vesting and disposed of 3,588 shares to cover tax obligations.

Summary

• Peter Kuan-How Lin, Chief Financial Officer of Apollomics Inc., reported the vesting of 10,000 Restricted Stock Units (RSUs) on June 15, 2026.
• Following the vesting, 3,588 shares were withheld by the company at a price of $13.85 per share to satisfy tax withholding requirements.
• The reporting person's total beneficial ownership of Class A Ordinary Shares stands at 22,312 following these transactions.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative event related to executive compensation, having no material impact on the company's operational outlook.

Positives

• The transaction reflects the scheduled vesting of equity compensation, indicating alignment between executive incentives and company performance.

Negatives

• The disposal of 3,588 shares, while for tax purposes, reduces the direct equity stake held by the CFO.

Risks

• Future RSU vesting is subject to continued employment and company performance milestones.

Future Outlook

The filing notes that an additional 10,000 shares are scheduled to vest on September 15, 2026.

Management Comments

• Each restricted stock unit represents a contingent right to receive one Class A Ordinary Share.

Industry Context

StockSavvy.ai notes that routine RSU vesting and tax-related share withholding are standard corporate governance practices for executive compensation in the biotechnology sector.

Comparison to Industry Standards

• The transaction follows standard SEC reporting requirements for executive equity compensation.
• Tax withholding via share cancellation is a common practice among publicly traded biotech firms to manage executive tax liabilities.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity compensation event.

Next Steps

• Vesting of 10,000 additional RSUs on September 15, 2026.

Key Dates

Keywords

Apollomics, APLM, Insider Trading, Form 4, CFO, Equity Compensation, Restricted Stock Units